A 30% reduction in the efficacy of antibiotics could increase infections and associated deaths for certain surgery and chemotherapy patients by 120,000 and 6,300 per year, respectively, according to a new study published online by The Lancet Infectious Diseases. The estimates are based on past controlled studies of the efficacy of antibiotics to prevent infections after 10 common surgical procedures and immunosuppressing cancer chemotherapies. “We can change the course of antibiotic resistance,” said study co-author Sumanth Gandra. “Antibiotic stewardship programs, improved hospital infection control, educating physicians and the public on proper use of antibiotics, widespread vaccination – all of these can make a difference in stopping dangerous infections.” The AHA’s Physician Leadership Forum last year released an antibiotic stewardship toolkit to help hospitals and health systems enhance their antimicrobial stewardship programs.

Related News Articles

Headline
In clinical trials involving 220,000 patients at 59 HCA Healthcare hospitals, algorithm-driven computerized alerts helped clinicians better identify the…
Headline
After declining in recent years, antimicrobial-resistant infections starting during hospitalization grew 15% from 2019 to 2020, the Centers for Disease Control…
Headline
The Centers for Disease Control and Prevention today updated its Core Elements for Hospital Antibiotic Stewardship Programs to reflect experience and evidence…
Headline
Antibiotic-resistant bacteria and fungi cause more than 2.8 million infections and 35,000 deaths in the United States each year, according to a report released…
Headline
The Department of Health and Human Services and Centers for Disease Control and Prevention last night celebrated nearly 350 organizations, including the AHA,…
Headline
The Food and Drug Administration yesterday approved a new antibiotic to treat adults with community-acquired bacterial pneumonia. The antibiotic, Xenleta…